These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
633 related items for PubMed ID: 12687927
1. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation]. Kosior D, Szulc M, Zawadzka M, Pierścińska M, Stawicki S, Rabczenko D, Torbicki A, Opolski G. Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927 [Abstract] [Full Text] [Related]
2. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation. Kosior D, Opolski G, Torbicki A. Med Sci Monit; 2001 Dec; 7(1):68-73. PubMed ID: 11208496 [Abstract] [Full Text] [Related]
3. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study. Kosior DA, Opolski G, Wozakowska-Kaplon B, Rabczenko D, Investigators of the HOT CAFE Polish Trial. Cardiology; 2005 Dec; 104(1):35-44. PubMed ID: 15942183 [Abstract] [Full Text] [Related]
4. Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation. Kosior DA, Wozakowska-Kapłon B, Jasik M, Kiliszek M, Rabczenko D, Opolski G. Kardiol Pol; 2005 Dec; 63(6):585-92; discussion 593-4. PubMed ID: 16380855 [Abstract] [Full Text] [Related]
5. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance. Galperín J, Elizari MV, Chiale PA, Molina RT, Ledesma R, Scapín AO, Blanco MV, Bonato R, Lago M, Grupo de Estudio de Fibrilación Auricular Con Amiodarona (GEFACA) Investigators. J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542 [Abstract] [Full Text] [Related]
6. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA. Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550 [Abstract] [Full Text] [Related]
7. Prognostic predictors of sinus rhythm control by amiodarone and electrical cardioversion in patients undergoing percutaneous transluminal mitral valvuloplasty for rheumatic atrial fibrillation. Guo GB, Hang CL, Chang HW, Wu CJ, Fang CY, Chen CJ. Circ J; 2007 Jul; 71(7):1115-9. PubMed ID: 17587720 [Abstract] [Full Text] [Related]
8. Atrial fibrillation: rate control often better than rhythm control. Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984 [Abstract] [Full Text] [Related]
9. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone. Kapoor A, Kumar S, Singh RK, Pandey CM, Sinha N. J Heart Valve Dis; 2002 Nov; 11(6):802-9. PubMed ID: 12479281 [Abstract] [Full Text] [Related]
10. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Opolski G, Stanisławska J, Górecki A, Swiecicka G, Torbicki A, Kraska T. Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591 [Abstract] [Full Text] [Related]
11. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial. Singh SN, Tang XC, Reda D, Singh BN. Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902 [Abstract] [Full Text] [Related]
12. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium]. Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A. Orv Hetil; 2004 May 09; 145(19):1001-6. PubMed ID: 15181735 [Abstract] [Full Text] [Related]
13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Cochrane Database Syst Rev; 2019 Sep 04; 9(9):CD005049. PubMed ID: 31483500 [Abstract] [Full Text] [Related]
14. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B. N Engl J Med; 2000 Mar 30; 342(13):913-20. PubMed ID: 10738049 [Abstract] [Full Text] [Related]
15. [Influence of sinus rhythm restoration and maintenance on left ventricle diameter and function in patients with persistent atrial fibrillation--one year follow-up]. Kosior DA, Szulc M, Stawicki S, Roik M, Rabczenko D, Opolski G. Pol Arch Med Wewn; 2005 Jan 30; 113(1):48-55. PubMed ID: 16130601 [Abstract] [Full Text] [Related]
16. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion. Kang JH, Lee DI, Kim S, Kim MN, Park YM, Ban JE, Choi JI, Lim HE, Park SW, Kim YH. J Cardiovasc Electrophysiol; 2012 Nov 30; 23(11):1165-70. PubMed ID: 22882453 [Abstract] [Full Text] [Related]
17. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion. Naji F, Suran D, Kanic V, Vokac D, Sabovic M. Med Sci Monit; 2009 Sep 30; 15(9):CR494-8. PubMed ID: 19721402 [Abstract] [Full Text] [Related]
18. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation? Tieleman RG, Van Gelder IC, Bosker HA, Kingma T, Wilde AA, Kirchhof CJ, Bennekers JH, Bracke FA, Veeger NJ, Haaksma J, Allessie MA, Crijns HJ. Heart Rhythm; 2005 Mar 30; 2(3):223-30. PubMed ID: 15851308 [Abstract] [Full Text] [Related]
19. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF. Eur Heart J; 2000 Jan 30; 21(1):66-73. PubMed ID: 10610746 [Abstract] [Full Text] [Related]
20. Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation. Zapolski T, Wysokiński A. Kardiol Pol; 2005 Sep 30; 63(3):254-62; discussion 263-4. PubMed ID: 16180181 [Abstract] [Full Text] [Related] Page: [Next] [New Search]